Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
Authors
Keywords
-
Journal
Nature Microbiology
Volume 6, Issue 1, Pages 11-18
Publisher
Springer Science and Business Media LLC
Online
2020-12-03
DOI
10.1038/s41564-020-00835-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Next-generation direct-acting influenza therapeutics
- (2020) Mart Toots et al. Translational Research
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
- (2020) Jianzhong Shi et al. SCIENCE
- Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
- (2020) Su-Jin Park et al. mBio
- SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
- (2020) Nadia Oreshkova et al. Eurosurveillance
- Age-dependent effects in the transmission and control of COVID-19 epidemics
- (2020) Nicholas G. Davies et al. NATURE MEDICINE
- Coronavirus rips through Dutch mink farms, triggering culls
- (2020) Martin Enserink SCIENCE
- SARS-CoV-2 is transmitted via contact and via the air between ferrets
- (2020) Mathilde Richard et al. Nature Communications
- Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase
- (2020) Robert M. Cox et al. Nature Microbiology
- Lung Expression of Human ACE2 Sensitizes the Mouse to SARS-CoV-2 Infection
- (2020) Kun Han et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19
- (2020) Martin Martinot et al. CLINICAL INFECTIOUS DISEASES
- Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review
- (2020) Sina Salajegheh Tazerji et al. Journal of Translational Medicine
- COVID has killed more than one million people. How many more will die?
- (2020) Emiliano Rodríguez Mega NATURE
- The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection
- (2019) George R. Painter et al. ANTIVIRAL RESEARCH
- Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
- (2019) Maria L. Agostini et al. JOURNAL OF VIROLOGY
- Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model
- (2019) Mart Toots et al. Translational Research
- Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
- (2018) Jeong-Joong Yoon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started